Price to Sales (P/S)155.81 Price to Cash Flow (P/CF)N/A P/FCF Ratio0.00 Enterprise Value/Market CapN/A Enterprise Value/RevenueN/A Enterprise Value/Gross ProfitN/A Enterprise Value/EbitdaN/A Forecast 1Y Price Target93.67p Price Target Upside34.33% Upside Rating ConsensusModerate Buy Number...
Price & Change Follow CMXHF CSL ― ― AMGN Amgen ― ― SNY Sanofi ― ― NVS Novartis ― ― BMY Bristol-Myers Squibb ― ― Compare AU:CSL Stocks > Best Analysts Covering CSL David LowJ.P. Morgan 1 Year Success Rate 8/13 ratings generated profit ...
(2024 - 2029)",studyPeriod:"2019-2029",countries:"",majorPlayers:"Nordex SE, Siemens Gamesa Renewable Energy SA, Vestas Wind Systems A/S, Suzlon Energy Limited, LM Wind Power (a GE Renewable Energy business)",majorPlayersImg:"https://s3.mordorintelligence.com/europe-rotor-blade-market/...
(2024 - 2029)",studyPeriod:"2019 - 2029",countries:"North America, Europe, Asia Pacific, Latin America, Middle East and Africa",majorPlayers:"General Dynamic, Airbus, Motorola Solutions, Telefonaktiebolaget LM Ericson, AT&T Intellectual Property",majorPlayersImg:"https://s3.mordorintelligence.com/...
Wireless Technology Table Of Content Loading Table Of Content... Individual sections of the reports are available for purchase. Would you like to see a breakdown of prices by section? Get Price Break-up Now *Terms and Conditions Apply
The report analyzes the profiles of key players operating in the 5G NTN market such as Qualcomm Technologies, Inc., Thales, ZTE Corporation, Rohde & Schwarz, MediaTek Inc., Nokia, Telefonaktiebolaget LM Ericsson, Intelsat, Spirent Communications, and Keysight Technologies. These players have adopted...
ITSA has been used for the assessment of a different type of interventions or event including health system reform [39], healthcare price reform, medical security policy reform [40], and so on. It was also used for the impact evaluation of MAs [30]. The two key variables in the model ...
(2012) bias-corrected scaled LM test (CDLMBCS)(CDLMBCS). The CDLMBCSCDLMBCS test statistic rejects the null hypothesis of no cross-section dependence for both the variables of log real dividends and share price. Hence, the result provides a clear picture of the presence of cross-section depe...
|| ShareSansar || No. 1 online financial portal of Nepal that provides a complete information of share market , Today's Share Price, Floor-sheet, Indices, Dividend, AGM, Book closure, Bonus,IPO, FPO, Right Share, Cash, Updated, Mutual fund, IPO, Com
305, a pre-clinical stage Antibody Drug Conjugate (ADC) targeting G protein-coupled receptor, class C, group 5, member D (GPRC5D), with AstraZeneca. AstraZeneca will be granted an exclusive global license to research, develop, and commercialize LM-305 under the terms of the licensing ...